The selective Aurora B kinase inhibitor AZD1152 as a novel treatment for hepatocellular carcinoma

Journal of Hepatology
Arihiro AiharaShigeki Arii

Abstract

We previously identified that high Aurora B expression was associated with hepatocellular carcinoma (HCC) recurrence due to tumor dissemination. In this preclinical study, a novel inhibitor of Aurora B kinase was evaluated as a treatment for human HCC. AZD1152 is a selective inhibitor of Aurora B kinase. Twelve human HCC cell lines were analyzed for Aurora B kinase expression and the in vitro effects of AZD1152. The in vivo effects of AZD1152 were analyzed in a subcutaneous xenograft model and a novel orthotopic liver xenograft model. Aurora B kinase expression varied among the human HCC cell lines and was found to correlate with inhibition of cell proliferation, accumulation of 4N DNA, and the proportion of polyploid cells following administration of AZD1152-hydroxyquinazoline-pyrazol-anilide (AZD1152-HQPA). AZD1152-HQPA suppressed histone H3 phosphorylation and induced cell death in a dose-dependent manner. Growth of subcutaneous human HCC xenografts was inhibited by AZD1152 administration. In an orthotopic hepatoma model, treatment with AZD1152 significantly decelerated tumor growth and increased survival. Pharmacobiological analysis revealed that AZD1152 induced the rapid suppression of phosphohistone H3, followed by cellul...Continue Reading

References

Mar 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·B BressacM Ozturk
Mar 11, 1999·The New England Journal of Medicine·N Ince, J R Wands
Nov 28, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S AriiR Yamada
Nov 24, 2001·Mutation Research·Donghui LiJames L Abbruzzese
Mar 27, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Shinji TanakaKeizo Sugimachi
Nov 20, 2003·Nature Reviews. Molecular Cell Biology·Mar Carmena, William C Earnshaw
Nov 25, 2004·The Journal of Clinical Endocrinology and Metabolism·Rosanna SorrentinoGiuseppe Portella
Dec 2, 2004·Nature Reviews. Cancer·Nicholas Keen, Stephen Taylor
May 4, 2005·Trends in Cell Biology·Régis GietClaude Prigent
May 26, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Esther RaskopfVolker Schmitz
Apr 6, 2006·Journal of the National Cancer Institute·Shinji TanakaShigeki Arii
May 19, 2006·Cancer Research·Edmund Chun Yu LeeNorman M Greenberg
Jul 5, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Chiara SonciniJürgen Moll
Aug 25, 2006·Nature Reviews. Cancer·Paraskevi A Farazi, Ronald A DePinho
Jun 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert W WilkinsonStephen Green
Jul 27, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yen-Shen LuChing-Shih Chen
Sep 27, 2007·Journal of the National Cancer Institute·Olivier TrédanIan F Tannock
Dec 20, 2007·Molecular Cancer Therapeutics·Patrizia CarpinelliJürgen Moll
Mar 19, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Oliver GautschiDavid R Gandara
Jun 10, 2008·Recent Patents on Anti-cancer Drug Discovery·Teresa MacarullaJosep Tabernero
Jul 25, 2008·The New England Journal of Medicine·Josep M LlovetUNKNOWN SHARP Investigators Study Group
Oct 17, 2008·The New England Journal of Medicine·Yujin HoshidaTodd R Golub
Oct 17, 2008·The New England Journal of Medicine·Morris Sherman
Dec 5, 2008·The New England Journal of Medicine·Giancarlo Spinzi, Silvia Paggi

❮ Previous
Next ❯

Citations

Jun 19, 2013·Chromosoma·Anna-Leena Salmela, Marko J Kallio
Aug 11, 2010·Journal of Molecular Modeling·Ping LanWei-Min Chen
May 28, 2010·International Journal of Clinical Oncology·Shinji Tanaka, Shigeki Arii
Jan 15, 2011·Annals of Surgery·Ayano MurakataShigeki Arii
Dec 29, 2013·Annals of Surgical Oncology·Kousuke OgawaShigeki Arii
Jul 31, 2013·International Journal of Clinical Oncology·Lkhagva-Ochir TovuuMitsuo Shimada
Feb 26, 2011·Journal of Gastroenterology·Shinji Tanaka, Shigeki Arii
Jan 12, 2016·Expert Review of Molecular Diagnostics·Fei Ma, Chun-yang Zhang
May 11, 2011·Expert Opinion on Drug Discovery·Myke R GreenDaruka Mahadevan
Aug 1, 2012·Seminars in Oncology·Shinji Tanaka, Shigeki Arii
Mar 3, 2012·International Journal of Radiation Oncology, Biology, Physics·Ali SakWilfried E E Eberhardt
Mar 5, 2016·Journal of Cancer Research and Clinical Oncology·Jonas Cicenas
Nov 15, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Kota SatoShigeki Arii
Oct 19, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Shinji TanakaShigeki Arii
Dec 20, 2014·Annals of Surgical Oncology·Hiroko MatsunagaMinoru Tanabe
May 20, 2011·Expert Opinion on Therapeutic Patents·Chun Hei Antonio CheungHsing-Pang Hsieh
May 19, 2017·Cell Death & Disease·Min-Jun WangYi-Ping Hu
Jun 24, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Arihiro AiharaJack R Wands
Feb 6, 2020·Aging·Melchiorre CervelloJames A McCubrey
Mar 3, 2012·Journal of Neuro-oncology·Roberto Jose DiazJames T Rutka
May 1, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Naheed Arfin Borah, Mamatha M Reddy
May 22, 2021·European Journal of Medicinal Chemistry·Tathagata PradhanVikramdeep Monga

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.